Glenmark Pharma

Glenmark Pharma to launch Micafungin for Injection USP in the US market

Top stocks in focus on July 14; DMart, Glenmark Pharma, VIP Industries, NCC, RITES, Ajmera Realty and more

Glenmark Pharma receives warning letter from US FDA for Indore facility

Glenmark Pharma shares surge 10% after its subsidiary signs $700 million licensing deal with AbbVie for ISB 2001

Top stocks in focus on July 11: Tata Steel, TCS, Tata Elxsi, Glenmark Pharma, HUL, JSW Infrastructure and more

Glenmark Pharma’s subsidiary IGI Therapeutics signs $700 million licensing deal with AbbVie for ISB 2001

Glenmark Pharma launches Vancomycin Hydrochloride for injection in the U.S.

Glenmark Pharma shares jump 4% as Q3 revenue jumps 35.1% YoY

Glenmark Pharma and Cosmo receives MHRA approval of Winlevi for treatment of acne

Glenmark Pharma Q2 results: Check share price ahead of Q2 results

Here’s why Glenmark Pharma stock jumps 7.15% in early trade – Check out the reason behind the surge

Glenmark Pharma shares surge over 6% today as Investec initiates ‘FAST Long’, expects 17% upside

Investec initiates ‘FAST Long’ on Glenmark Pharma, expects stock to rally 17%

Investec has initiated coverage on Glenmark Pharmaceuticals with a "FAST long" recommendation, setting a target price of Rs 1900, which implies a 17.6% upside from the previous close of Rs 1615.

Glenmark Pharma receives zero observations from U.S. FDA at Aurangabad facility

Glenmark Pharma settles US investigation with $25 million payment over five years